When taking Ubrelvy (ubrogepant), it is important to avoid certain medications due to potential interactions that could increase the risk of side effects.
What drugs should not be taken with Ubrelvy?
Ubrelvy should not be taken with certain medications that affect how the liver breaks down drugs. Specifically, strong inhibitors of the CYP3A4 enzyme should be avoided [1]. Examples of such strong inhibitors include ketoconazole, itraconazole, clarithromycin, ritonavir, and nelfinavir [1]. Additionally, moderate inhibitors of CYP3A4 should be used with caution [1].
What are the risks of taking Ubrelvy with other medications?
Taking Ubrelvy with medications that inhibit CYP3A4 can increase the concentration of ubrogepant in the body. This elevated level can lead to an increased risk of side effects, such as gastrointestinal problems or central nervous system effects [1]. The prescribing information for Ubrelvy also advises against its use with strong inhibitors of the P-glycoprotein (P-gp) transporter [1].
Can I take Ubrelvy with other migraine medications?
The safety and efficacy of taking Ubrelvy concurrently with other migraine medications, such as triptans or ergots, have not been established [1]. Therefore, it is generally recommended to avoid using them together.
How does Ubrelvy work, and why do drug interactions occur?
Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor antagonist used to treat acute migraine [1]. Drug interactions occur because both Ubrelvy and many other medications are processed by enzymes in the liver, particularly the CYP3A4 enzyme, and transporters like P-gp. When a substance inhibits these enzymes or transporters, it can slow down the breakdown of Ubrelvy, leading to higher levels in the bloodstream [1].
When does Ubrelvy patent expiry occur?
Information on the specific patent expiry dates for Ubrelvy can be found on patent tracking websites [2]. These dates are crucial for understanding when generic versions of the drug may become available.
Who manufactures Ubrelvy?
Ubrelvy is manufactured by AbbVie [1].
Sources:
[1] https://www.ubrelvy.com/
[2] https://drugpatentwatch.com/